FDA Inspection
David F. Jativa, M.D.David F. Jativa, M.D. – FDA Inspection, Apr 25, 2022
Record Details
This FDA Inspection record concerns David F. Jativa, M.D., with an inspection on April 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David F. Jativa, M.D.
- Inspection Date
- April 25, 2022
- Product Type
- Drugs
View Company Profile
ID · aaf1a13f-b422-48b6-8ea4-13c95cd70c94
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1167842
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David F. Jativa, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2026 | Not classified | Florida District Office |
Other documents for David F. Jativa, M.D.
- FDA Inspection 1304432 - 2026-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.